EARNINGSCognyte Software narrows full-year guidance to $448 million on software mix shift and profitability accelerationSep 10, 2026
DEALSKTHAF declares THB 0.48 per-share cash dividend, ex-date and record date 23 September 2026Sep 10, 2026
DEALSTreasury's $6bn buyback fails to halt 30-year yield at 5.2%Sep 10, 2026
WORLDChina regulators warn banks against flooding IPO market with low-quality listingsSep 10, 2026
EARNINGSJ.J. McCarthy demoted to third string as Vikings name Wentz backup ahead of Green Bay openerSep 10, 2026
KALAKALA BIO sets November 3 annual meeting; stockholder nomination window closes September 19Sep 9, 2026
MACROTwenty-nine health systems plan to exit Medicare AdvantageSep 9, 2026
MACROCopper hits record $14,858.50 a ton as tariff stockpiling and global supply crunch convergeSep 9, 2026
EARNINGSCognyte Software narrows full-year guidance to $448 million on software mix shift and profitability accelerationSep 10, 2026
DEALSKTHAF declares THB 0.48 per-share cash dividend, ex-date and record date 23 September 2026Sep 10, 2026
DEALSTreasury's $6bn buyback fails to halt 30-year yield at 5.2%Sep 10, 2026
WORLDChina regulators warn banks against flooding IPO market with low-quality listingsSep 10, 2026
EARNINGSJ.J. McCarthy demoted to third string as Vikings name Wentz backup ahead of Green Bay openerSep 10, 2026
KALAKALA BIO sets November 3 annual meeting; stockholder nomination window closes September 19Sep 9, 2026
MACROTwenty-nine health systems plan to exit Medicare AdvantageSep 9, 2026
MACROCopper hits record $14,858.50 a ton as tariff stockpiling and global supply crunch convergeSep 9, 2026

Eli Lilly pays $2.8 billion for psychedelics maker AtaiBeckley

$2.8 billion is what Eli Lilly has agreed to pay for AtaiBeckley, a maker of experimental psychedelic-based drugs. The deal hands Lilly a pipeline built on DMT and MDMA, two compounds drawing growing pharmaceutical attention. The…

By Warren Ashby·Jul 17, 2026·1 min read·markets·LLY
Share
Source: cnbc.com
© 2026 NewsMeter